AR and fatty liver disease: Furthermore, the blockade of AR in aldolase B KO mice was associated with a marked improvement of liver injury, as denoted by fat mobilization and low liver steatosis and inflammation (Figure 2M), injury score (Figure 2N) and significantly lower plasma levels of liver transaminases ALT and AST (Figure 2O,P).